{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:33:57Z","timestamp":1787164437662,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Invasive infection remains a dangerous complication of heart transplantation (HT). No objectively defined set of clinical risk factors has been established to reliably predict infection in HT. The aim of this study was to develop a clinical prediction model for use at 1 mo post-HT to predict serious infection by 1 y.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>A retrospective cohort study of HT recipients (2000\u20132018) was performed. The composite endpoint included cytomegalovirus (CMV), herpes simplex or varicella zoster virus infection, blood stream infection, invasive fungal, or nocardial infection occurring 1 mo to 1 y post-HT. A least absolute shrinkage and selection operator regression model was constructed using 10 candidate variables. A concordance statistic, calibration curve, and mean calibration error were calculated. A scoring system was derived for ease of clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Three hundred seventy-five patients were analyzed; 93 patients experienced an outcome event. All variables remained in the final model: aged 55 y or above, history of diabetes, need for renal replacement therapy in first month, CMV risk derived from donor and recipient serology, use of induction and\/or early lymphodepleting therapy in the first month, use of trimethoprim-sulfamethoxazole prophylaxis at 1 mo, lymphocyte count under 0.75\u2009\u00d7\u200910\n                      <jats:sup>3<\/jats:sup>\n                      cells\/\u00b5L at 1 mo, and inpatient status at 1 mo. Good discrimination (C-index 0.80) and calibration (mean absolute calibration error 3.6%) were demonstrated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion.<\/jats:title>\n                    <jats:p>This model synthesizes multiple highly relevant clinical parameters, available at 1 mo post-HT, into a unified, objective, and clinically useful prediction tool for occurrence of serious infection by 1 y post-HT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001542","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T18:00:47Z","timestamp":1698948047000},"page":"e1542","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A Clinical Model to Predict the Occurrence of Select High-risk Infections in the First Year Following Heart Transplantation"],"prefix":"10.1097","volume":"9","author":[{"given":"Whitney A.","family":"Perry","sequence":"first","affiliation":[{"name":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Chow","sequence":"additional","affiliation":[{"name":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Nelson","sequence":"additional","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Kent","sequence":"additional","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Snydman","sequence":"additional","affiliation":[{"name":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/lt.23497","article-title":"ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis.","volume":"18","author":"Rodrigo","year":"2012","journal-title":"Liver Transpl"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/ajt.15315","article-title":"A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients.","volume":"9","author":"Kumar","year":"2019","journal-title":"Am J Transplant"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"e13550","DOI":"10.1111\/tid.13550","article-title":"Evaluation of Quantiferon\u00ae-Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients.","volume":"23","author":"Gardiner","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/TP.0000000000002454","article-title":"A Randomized Study of quantiferon CMV-directed versus fixed-duration valganciclovir prophylaxis to reduce late CMV after lung transplantation.","volume":"103","author":"Westall","year":"2019","journal-title":"Transplantation"},{"key":"R5-20240805","first-page":"1497","article-title":"Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation.","volume":"20","author":"Nierenberg","year":"2014","journal-title":"Liver Transpl"},{"key":"R6-20240805","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(97)80021-6","article-title":"The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients Boston Center for Liver Transplantation CMVIG-Study Group Cytogam, MedImmune, Inc Gaithersburg, Maryland.","volume":"103","author":"George","year":"1997","journal-title":"Am J Med"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/INF.0000000000000811","article-title":"Risk factors for bloodstream infection after living-donor liver transplantation in children.","volume":"34","author":"Shoji","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.tp.0000188953.86035.2d","article-title":"Bloodstream infections among heart transplant recipients.","volume":"81","author":"Rodr\u00edguez","year":"2006","journal-title":"Transplantation"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/514340","article-title":"Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study.","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"eaax9856","DOI":"10.1126\/sciadv.aax9856","article-title":"Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function.","volume":"6","author":"Sen","year":"2020","journal-title":"Sci Adv"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The Third International Consensus Guidelines on the Management of cytomegalovirus in solid-organ transplantation.","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials.","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R13-20240805","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1001\/archinte.1994.00420230024004","article-title":"Influence of blood culture results on antibiotic choice in the treatment of bacteremia.","volume":"154","author":"Arbo","year":"1994","journal-title":"Arch Intern Med"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"e13509","DOI":"10.1111\/ctr.13509","article-title":"Nocardia infections in solid organ transplantation: guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation.","volume":"33","author":"Restrepo","year":"2019","journal-title":"Clin Transplant"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/01.tp.0000226068.66819.37","article-title":"Infection frequency and profile in different age groups of kidney transplant recipients.","volume":"81","author":"Dharnidharka","year":"2006","journal-title":"Transplantation"},{"key":"R17-20240805","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.healun.2010.05.003","article-title":"Balancing rejection and infection with respect to age, race, and gender: clues acquired from 17 years of cardiac transplantation data.","volume":"29","author":"George","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1046\/j.1523-1755.2001.0590041539.x","article-title":"Exponentially increased risk of infectious death in older renal transplant recipients.","volume":"59","author":"Meier-Kriesche","year":"2001","journal-title":"Kidney Int"},{"key":"R19-20240805","first-page":"381","article-title":"Infection after heart transplantation: a multiinstitutional study Cardiac Transplant Research Database Group.","volume":"13","author":"Miller","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"R20-20240805","first-page":"329","article-title":"Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study.","volume":"15","author":"Smart","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"e3797","DOI":"10.1093\/cid\/ciaa1800","article-title":"Association between lymphopenia at one month post-transplant and infectious outcomes or death in heart transplant recipients.","volume":"73","author":"Perry","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"e13519","DOI":"10.1111\/tid.13519","article-title":"Epidemiology and risk factors for varicella zoster virus reactivation in heart transplant recipients.","volume":"23","author":"La Hoz","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R23-20240805","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/tid.12149","article-title":"Incidence and risk factors for herpes zoster following heart transplantation.","volume":"16","author":"Koo","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R24-20240805","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.transproceed.2014.08.043","article-title":"Incidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipients.","volume":"46","author":"Santos","year":"2014","journal-title":"Transplant Proc"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R31-20240805","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/cid\/ciy295","article-title":"Absolute lymphocyte count: a predictor of recurrent cytomegalovirus disease in solid organ transplant recipients.","volume":"67","author":"Gardiner","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R32-20240805","doi-asserted-by":"crossref","first-page":"ofy230","DOI":"10.1093\/ofid\/ofy230","article-title":"Absolute lymphocyte count thresholds: a simple, readily available tool to predict the risk of cytomegalovirus infection after transplantation.","volume":"5","author":"Meesing","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"R33-20240805","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/lt.21833","article-title":"Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation.","volume":"15","author":"Fern\u00e1ndez-Ruiz","year":"2009","journal-title":"Liver Transpl"},{"key":"R34-20240805","doi-asserted-by":"crossref","first-page":"682","DOI":"10.12659\/AOT.905267","article-title":"Heart transplantation and risk of cardiac vasculopathy development: what factors are important?","volume":"22","author":"Sobieszcza\u0144ska-Ma\u0142ek","year":"2017","journal-title":"Ann Transplant"},{"key":"R35-20240805","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/tid.12284","article-title":"Evaluation of an immunological score to assess the risk of severe infection in heart recipients.","volume":"16","author":"Sarmiento","year":"2014","journal-title":"Transpl Infect Dis"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:06:30Z","timestamp":1722816390000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001542","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]}}}